Literature DB >> 26750428

Differences in the associations of anthropometric measures with insulin resistance and type 2 diabetes mellitus between Korean and US populations: Comparisons of representative nationwide sample data.

Yeong Sook Yoon1, Han Seok Choi2, Jin Kuk Kim3, Yu Il Kim4, Sang Woo Oh5.   

Abstract

BACKGROUNDS: Variation among ethnic groups in the association between obesity and insulin resistance (IR)/diabetes has been suggested, but studies reported inconsistent results. We evaluated ethnic differences in the association between obesity and insulin resistance (IR)/diabetes.
METHODS: We conducted a cross-sectional analysis using Korea (n=18,845) and the USA (n=4657) National Health and Nutrition Examination Survey(NHANES) 2007-2010. We performed statistical comparisons of AUC-ROC (area under the curve in a receiver operating characteristic curve) values for body mass index (BMI), waist circumference (WC) and homeostasis model assessment of insulin resistance (HOMA-IR) to predict IR or diabetes among different ethnic groups.
RESULTS: AUC-ROC values for BMI and WC for predicting IR were highest in Whites (0.8324 and 0.8468) and lowest in Koreans (0.7422 and 0.7367). Whites showed the highest AUC-ROC values for BMI (0.6869) and WC (0.7421) for predicting diabetes, while the AUC-ROC for HOMA-IR was highest in Koreans (0.8861). Linear regression showed significant interactions between ethnicity and the main effects (all P<0.0001). Increases in BMI were associated with a larger increase in HOMA-IR in Whites (β=0.0719) and WC in Hispanics (β=0.0324), while BMI was associated with a larger increase in fasting glucose in Koreans (β=0.8279) and WC in Blacks (β=0.4037). In addition, the slope for fasting glucose with increasing HOMA-IR was steeper in Koreans (β=16.5952, P<0.001) than in other groups.
CONCLUSION: The ability of BMI and WC to predict IR and diabetes was highest in Whites, while the ability of HOMA-IR to predict diabetes was highest in Koreans.
Copyright © 2015 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Ethnic differences; Insulin resistance; Type 2 diabetes; Waist circumference

Mesh:

Substances:

Year:  2015        PMID: 26750428     DOI: 10.1016/j.orcp.2015.11.001

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  5 in total

1.  Are body mass index and waist circumference significant predictors of diabetes and prediabetes risk: Results from a population based cohort study.

Authors:  Fahimeh Haghighatdoost; Masoud Amini; Awat Feizi; Bijan Iraj
Journal:  World J Diabetes       Date:  2017-07-15

2.  Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial.

Authors:  Kyung Wan Min; Bon Jeong Ku; Ji Hyun Lee; Min Seon Kim; Kyu Jeung Ahn; Moon Kyu Lee; Satoshi Kokubo; Satoshi Yoshida; Hyun Ji Cho; Bong Soo Cha
Journal:  Diabetes Metab J       Date:  2017-04       Impact factor: 5.376

3.  Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response.

Authors:  Tianwei Gu; Ting Hong; Pengzi Zhang; Sunyinyan Tang; Yan Bi; Hai Lu; Lichuang Men; Dongwei Ma; Dalong Zhu
Journal:  Diabetes Ther       Date:  2018-03-09       Impact factor: 2.945

Review 4.  Common Pitfalls in the Interpretation of Endocrine Tests.

Authors:  Jose C Alvarez-Payares; Jesus David Bello-Simanca; Edwin De Jesus De La Peña-Arrieta; Jose Emilio Agamez-Gomez; Jhon Edwar Garcia-Rueda; Amilkar Rodriguez-Arrieta; Luis Antonio Rodriguez-Arrieta
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-07       Impact factor: 5.555

5.  Physical activity status by pain severity in patients with knee osteoarthritis: a nationwide study in Korea.

Authors:  Hye-Young Shim; Mira Park; Hee-June Kim; Hee-Soo Kyung; Ji-Yeon Shin
Journal:  BMC Musculoskelet Disord       Date:  2018-10-20       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.